Category survey

Development and Use of a Context-Rich Virtual Learning Environment for Practicing Interpersonal Communication Skills

Development and Use of a Context-Rich Virtual Learning Environment for Practicing Interpersonal Communication Skills Investments < €500k Australia 2016

Targeting chaperone mediated autophagy to aleviate Aβ accumulation and toxicity in AD

Targeting chaperone mediated autophagy to aleviate Aβ accumulation and toxicity in AD Investments < €500k Australia 2016

Geographic Gerontology and Dementia Friendly Environments: Illuminating perspectives of people with dementia and carers

Geographic Gerontology and Dementia Friendly Environments: Illuminating perspectives of people with dementia and carers Investments < €500k Australia 2016

Evaluation of a 12-week combined psychoeducation and home-based exercise program on mood and wellbeing in older adults with early Alzheimer’s disease.

Evaluation of a 12-week combined psychoeducation and home-based exercise program on mood and wellbeing in older adults with early Alzheimer’s disease. Investments < €500k Australia 2016

Improving Quality of Life for People with Dementia: Development and Evaluation of a 3D Virtual World

Improving Quality of Life for People with Dementia: Development and Evaluation of a 3D Virtual World Investments < €500k Australia 2016

Investigating peripheral biochemical changes during familial Alzheimer’s disease progression

Investigating peripheral biochemical changes during familial Alzheimer’s disease progression Investments < €500k Australia 2016

Targeting mitochondrial dysfunction as a potential therapy for the prevention of neurodegenerative disorders including Alzheimer’s Disease (AD)

Targeting mitochondrial dysfunction as a potential therapy for the prevention of neurodegenerative disorders including Alzheimer’s Disease (AD) Investments < €500k Australia 2016

A randomized controlled trial of Theta Burst Stimulation for the treatment of cogntive impairment in mild to moderate Alzheimer’s disease

A randomized controlled trial of Theta Burst Stimulation for the treatment of cogntive impairment in mild to moderate Alzheimer’s disease Investments < €500k Australia 2016

Restoring Neuroprotective Sphingosine 1-phosphate Signalling in Alzheimer’s Disease

Restoring Neuroprotective Sphingosine 1-phosphate Signalling in Alzheimer’s Disease Investments < €500k Australia 2016

Understanding how vessel fragility contributes to Alzheimer’s disease

Understanding how vessel fragility contributes to Alzheimer’s disease Investments < €500k Australia 2016

Microvascular breakdown: At the core of plaque formation and neuronal pathology in Alzheimer’s disease

Microvascular breakdown: At the core of plaque formation and neuronal pathology in Alzheimer’s disease Investments < €500k Australia 2016

Establishment of Sil1 as a novel drug target for Alzheimer’s disease

Establishment of Sil1 as a novel drug target for Alzheimer’s disease Investments < €500k Australia 2016

Impact of genetics on the effect that modifiable lifestyle factors have on rates of change in Alzheimer’s Disease

Impact of genetics on the effect that modifiable lifestyle factors have on rates of change in Alzheimer’s Disease Investments < €500k Australia 2016

Investigating the utility of oxidative stress as a biomarker for cognitive decline and dementia: a longitudinal magnetic resonance imaging study in ‘at risk’ older adults and Alzheimer’s disease.

Investigating the utility of oxidative stress as a biomarker for cognitive decline and dementia: a longitudinal magnetic resonance imaging study in ‘at risk’ older adults and Alzheimer’s disease. Investments < €500k Australia 2016

The DOGS+CELLS Trial: A new pathway to treating Alzheimer’s dementia

The DOGS+CELLS Trial: A new pathway to treating Alzheimer’s dementia Investments < €500k Australia 2016

A Multi-Target Approach to Alzheimer’s Disease: Novel Polyfunctional Therapeutics that Target Multiple Hallmarks

A Multi-Target Approach to Alzheimer’s Disease: Novel Polyfunctional Therapeutics that Target Multiple Hallmarks Investments < €500k Australia 2016

Identifying the functional link between cell adhesion and the cytoskeleton at synapses in Alzheimer’s disease

Identifying the functional link between cell adhesion and the cytoskeleton at synapses in Alzheimer’s disease Investments < €500k Australia 2016

Development of a comprehensive specialist support service to enhance the experiences of younger people with Huntingtons disease in residential care

Development of a comprehensive specialist support service to enhance the experiences of younger people with Huntingtons disease in residential care Investments < €500k Australia 2016

Silver Memories as Music Therapy

Silver Memories as Music Therapy Investments < €500k Australia 2016

Dementia Care Tool

Dementia Care Tool Investments < €500k Australia 2016

Dementia Specialist

Dementia Specialist Investments < €500k Australia 2016

Tracking disease progression in Parkinson’s Disease using new postural and brain imaging measures

Tracking disease progression in Parkinson’s Disease using new postural and brain imaging measures Investments < €500k Australia 2016

Mechanisms of T-regulatory cell protection in MND

Mechanisms of T-regulatory cell protection in MND Investments < €500k Australia 2016

Hotspots of dementia risk in Australian communities: an approach to better targeting preventive interventions

Hotspots of dementia risk in Australian communities: an approach to better targeting preventive interventions Investments < €500k Australia 2016

Psychological and nutritional determinants of telomere and genome integrity in dementia carers

Psychological and nutritional determinants of telomere and genome integrity in dementia carers Investments < €500k Australia 2016

A novel approach to enhance cognitive function and promote synaptic plasticity

A novel approach to enhance cognitive function and promote synaptic plasticity Investments < €500k Australia 2016

Modifying the Trajectory of Insidious Late Life Cognitive Decline using Computerised Cognitive Training

Modifying the Trajectory of Insidious Late Life Cognitive Decline using Computerised Cognitive Training Investments < €500k Australia 2016

Investigating secondary effects of a promising therapeutic strategy for Alzheimer’s disease

Investigating secondary effects of a promising therapeutic strategy for Alzheimer’s disease Investments < €500k Australia 2016

Healthcare interventions and Alzheimer’s Disease (AHEAD)

Healthcare interventions and Alzheimer’s Disease (AHEAD) Investments < €500k Australia 2016

Membrane trafficking of BACE1 and amyloid precursor protein in primary neurons and the production of Abeta amyloid peptides

Membrane trafficking of BACE1 and amyloid precursor protein in primary neurons and the production of Abeta amyloid peptides Investments < €500k Australia 2016

Agents targeting iron in the brain in Parkinson’s disease

Agents targeting iron in the brain in Parkinson’s disease Investments < €500k Australia 2016

The role of a presenilin 2 truncation (PS2V) in Alzheimer’s Disease

The role of a presenilin 2 truncation (PS2V) in Alzheimer’s Disease Investments < €500k Australia 2016

Disruption to intracellular trafficking as a central pathogenic mechanism in amyotrophic lateral sclerosis (ALS)

Disruption to intracellular trafficking as a central pathogenic mechanism in amyotrophic lateral sclerosis (ALS) Investments < €500k Australia 2016

Pathogenic and adaptive molecular interactions with mutant huntingtin exon 1

Pathogenic and adaptive molecular interactions with mutant huntingtin exon 1 Investments < €500k Australia 2016

Identification of dementia and motor neuron disease genes

Identification of dementia and motor neuron disease genes Investments < €500k Australia 2016

Dementia related deficits in striatal cholinergic function and decision-making

Dementia related deficits in striatal cholinergic function and decision-making Investments < €500k Australia 2016

How road blocks form in nerve cells, impair trafficking and contribute to Alzheimers disease

How road blocks form in nerve cells, impair trafficking and contribute to Alzheimers disease Investments < €500k Australia 2016

TRP channels, calcium and AD

TRP channels, calcium and AD Investments < €500k Australia 2016

Defining the changes in cell biology caused by PRESENILIN truncations associated with different diseases

Defining the changes in cell biology caused by PRESENILIN truncations associated with different diseases Investments < €500k Australia 2016

Neuronal hyperactivity and neurotrophic factors in motor neuron disease

Neuronal hyperactivity and neurotrophic factors in motor neuron disease Investments < €500k Australia 2016

A novel roadblock to vitamin B12 transport in the brain

A novel roadblock to vitamin B12 transport in the brain Investments < €500k Australia 2016

Gene-environment interactions modulating cognition and dementia in Huntingtons disease

Gene-environment interactions modulating cognition and dementia in Huntingtons disease Investments < €500k Australia 2016

SMN immunogene therapy for motor neuron disorders

SMN immunogene therapy for motor neuron disorders Investments < €500k Australia 2016

Isoform-dependent apoE processing by human induced pluripotent stem cells. A novel pathway linking APOE genotype and Alzheimer’s disease risk.

Isoform-dependent apoE processing by human induced pluripotent stem cells. A novel pathway linking APOE genotype and Alzheimer’s disease risk. Investments < €500k Australia 2016